Literature DB >> 1708340

Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60.

A Wand-Württenberger1, B Schoel, J Ivanyi, S H Kaufmann.   

Abstract

Bone marrow-derived macrophages were stained with a variety of monoclonal antibodies (mAb) with specificity for the mycobacterial heat shock protein (hsp) 60 or with specific rabbit antiserum raised against mycobacterial hsp 60. The mAb ML30 as well as the specific antiserum brightly stained bone marrow-derived macrophages whereas all the other mAb as well as normal rabbit antiserum gave no or negligible reactivity. Surface expression of the shared epitope is observed by day 3 of in vitro cultivation and markedly increased by interferon-gamma stimulation on day 9. Although hsp 60 is thought to be restricted to the mitochondrial compartment, antibody responses to this molecule have been implicated in autoimmunity. Our finding that bone marrow-derived macrophages express a cross-reactive epitope recognized by an mAb with specificity for amino acids 275 to 295 of the mycobacterial hsp 60 is consistent with such a role.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708340     DOI: 10.1002/eji.1830210437

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Expression of 60 kDa heat shock protein (Hsp60) on plasma membrane of Daudi cells.

Authors:  Rosella Cicconi; Andrea Delpino; Pierluca Piselli; Mauro Castelli; Daniela Vismara
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

2.  Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.

Authors:  M Radwanska; S Magez; A Michel; B Stijlemans; M Geuskens; E Pays
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Surface expressed heat-shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity.

Authors:  S Di Cesare; F Poccia; A Mastino; V Colizzi
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis.

Authors:  M Stahl; D Ludwig; K Fellermann; E F Stange
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

Review 5.  Bacterial Heat Shock Protein Activity.

Authors:  Farajollah Maleki; Afra Khosravi; Ahmad Nasser; Hamid Taghinejad; Mitra Azizian
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  Immunohistochemical study of gamma delta T cell receptor-positive cells in the capsular region of hepatocellular carcinoma: possible role in defense against expansion of carcinoma in the liver.

Authors:  K Chin; K Morise; K Kanayama; H Nagura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

7.  Relation between antibodies to Chlamydia trachomatis and spontaneous abortion following in vitro fertilization.

Authors:  F Licciardi; J A Grifo; Z Rosenwaks; S S Witkin
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

8.  Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection.

Authors:  T Arai; K Hiromatsu; H Nishimura; Y Kimura; N Kobayashi; H Ishida; Y Nimura; Y Yoshikai
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice.

Authors:  M Tsuji; P Mombaerts; L Lefrancois; R S Nussenzweig; F Zavala; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

Review 10.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.